Inhibitory effect of suramin on receptor binding and cytotoxic activity of tumor necrosis factor α
- 31 May 1992
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 14 (4), 637-642
- https://doi.org/10.1016/0192-0561(92)90125-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Synergistic Activity of Suramin With Tumor Necrosis Factor and Doxorubicin on Human Prostate Cancer Cell LinesJNCI Journal of the National Cancer Institute, 1990
- Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.The Journal of Experimental Medicine, 1989
- Peptide Regulatory FactorsThe Lancet, 1989
- Tumor Necrosis Factor (Cachectin) as an Essential Mediator in Murine Cerebral MalariaScience, 1987
- Tumors secreting human TNF/cachectin induce cachexia in miceCell, 1987
- Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cellsJournal of Cellular Physiology, 1987
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Suramin binds to platelet‐derived growth factor and inhibits its biological activityJournal of Cellular Biochemistry, 1985
- Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor virusesCancer Letters, 1979
- Suramin: A potent ATPase inhibitor which acts on the inside surface of the sodium pumpBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973